AgeX Therapeutics, Inc. (AGE)

Operating Cash Flow (Statement)

-$21.14M

TTM · Period ending: · USD

AGE logo

AGE Operating Cash Flow (Statement)

Latest reported-$21.14M
AGE Cash from Operations (-$6.29M → -$21.14M)
High-resolution chart · PNG

AGE operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-17,955,000
-17,137,000
-7,800,000
-5,939,000
-7,855,000
-7,817,000
-10,160,000
-7,995,000
-6,285,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.